NCT04574895View on ClinicalTrials.gov

Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events

NACompletedINTERVENTIONAL

Enrollment

17,427

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

December 1, 2023

Conditions

Venous ThromboembolismPediatricsDeep Vein ThrombosisPulmonary Embolism

Interventions

OTHER

Hematology Review

VTE study team will review VTE risk percentages provided via automated report daily on weekdays and approach the primary team directly if the patient is appropriate for clinical antithrombotic interventions.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER

NCT04574895 - Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events | Biotech Hunter | Biotech Hunter